FOPE urges DCGI to review the list of 35 unapproved FDCs for manufacture and marketing
The Federation of Pharma Entrepreneurs (FOPE) has urged the Drugs Controller General of India (DCGI) to review the list of 35 unapproved fixed dose combination (FDC) drugs. Three weeks ago, the DCGI had released a list of 35 unapproved FDCs which were …